Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





DIAZINON								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 333-41-5; **Chemical Formula:** C12H21N2O3PS
Previously, OSHA had no limit for diazinon. The ACGIH has a TLV-TWA of 0.1 mg/m3, with a skin notation. The proposed PEL was an 8-hour TWA of 0.1 mg/m3, with a skin notation; NIOSH concurs that these limits are appropriate (Ex. 8-47, Table N1). The final rule establishes a 0.1-mg/m3 PEL, with a skin notation, for diazinon. Pure diazinon is a colorless liquid, but the technical grade is pale yellow to dark brown in color and has a faint odor.
Gaines (1960/Ex. 1-319) reports the acute oral LD(50) for male and female rats to be 108 and 76 mg/kg, respectively. Other reports set the acute oral LD(50)s in rats, guinea pigs, and rabbits at 76 to 150, 240 to 320, and 130 mg/kg, respectively (Association of American Pesticide Control Officials, Inc. 1969, as cited in ACGIH 1986/Ex. 1-3, p. 172). Studies from Hazleton Laboratories (1965, as cited in ACGIH 1986/Ex. 1-3, p. 172) and Radeleff (1958/Ex. 1-434) have shown much greater susceptibility to diazinon in birds and calves, with the oral LD(50) being less than 10 mg/kg in some instances. The dermal LD(50) in rabbits is 400 mg/kg (RTECS 1983-84). However, susceptibility to repeated doses is relatively consistent among species, with dogs showing signs of poisoning at 9.3 mg/kg per day and rats showing complete inhibition of red blood cell cholinesterase and marked inhibition of brain cholinesterase at 50 mg/kg/day (Bruce, Howard, and Elsea 1955/Ex. 1-585). Monkeys were poisoned at 5 mg/kg/day (Woodard, Woodard, and Cronin 1968/Ex. 1-458). Chronic feeding studies in rats have shown no chronic toxicity at 10, 100, and 1000 ppm. For many mammals, diazinon is less toxic than parathion (ACGIH TLV-TWA of 0.1 mg/m3), although this is not true under some circumstances (ACGIH 1986/Ex. 1-3, p. 172).
In humans, Hayes (1963/Ex. 1-982) reports that two patients were poisoned by a dermal diazinon dosage of about 1.1 mg/kg; however, Gassman (1957/Ex. 1-901) reports no ill effects from an accidental ingestion of 30 mg/kg. One man received a dose of 250 mg/kg and recovered after treatment, which included gastric lavage (Bockel 1967, as cited in ACGIH 1986/Ex. 1-3, p. 172). In tests, Geigy (1966, as cited in ACGIH 1986/Ex. 1-3, p. 172) found that a series of doses of 0.05 mg/kg/day for 28 days produced plasma cholinesterase inhibition, and it has been suggested that the no-effect level for cholinesterase inhibition in humans is 0.02 mg/kg/day. Skin absorption of diazinon occurs readily, and overexposures are associated with weakness, headache, blurred vision, salivation, sweating, nausea, vomiting, diarrhea, abdominal cramps, slurred speech, and moist rales in the lungs (ACGIH 1986/Ex. 1-3, p. 172).
In the final rule, the Agency is establishing an 8-hour TWA PEL of 0.1 mg/m3, with a skin notation, for diazinon. OSHA concludes that these limits will protect exposed workers from the significant risk of cholinesterase inhibition, weakness, headache, nausea, vomiting, as well as the other symptoms and signs of diazinon poisoning, which together constitute material health impairments that are associated with exposures at levels above the new PEL.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue